Pacira BioSciences CFO Executes Stock Sale Following Option Exercise
Pacira BioSciences, Inc. (NASDAQ:PCRX) disclosed through a recent SEC filing that its Chief Financial Officer, Shawn Cross, conducted a series of stock transactions on April 23, 2026. The activity involved both the exercise of stock options and a subsequent sale of common stock, totaling $325,595 in proceeds from the disposal.The transaction sequen…